MiddleBrook files for Ch. 11

WESTLAKE, Texas The maker of a long-acting formulation of the antibiotic amoxicillin has filed for bankruptcy.

MiddleBrook Pharmaceuticals, the maker of Moxatag, said Friday that it would file for Chapter 11 bankruptcy protection, but would continue to manage and operate its business and assets during the pendency of the bankruptcy case.

“During this process, we remain committed to continuing to promote Moxatag through our third-party partner’s electronic promotion program and maintaining product availability to our trade customers,” MiddleBrook EVP and CFO and acting president and CEO David Becker said.

The company said it expected to receive notification from Nasdaq that its stock would be delisted due to failure to pay required fees.